5National institutes of health(NIH).National Heart,Lung and Blood Institute (NHLBI)/World Health Organization (WHO).Global strategy for asthma management and prevention.Global initiative for asthma.No.02-3659.NIH Publication,2002.1-172.
6Holgate ST.Therapeutic options for persistent asthma.JAMA,2001,285:2637-2639.
7Nelson HS,Chapman KR,Pyke SD,et al.Enhanced synergy between fluticasone propionate and salmeterol inhaled from a single inhaler versus separate inhalers.J Allergy Clin Immunol,2003,112:29-36.
8Pauwels RA,Lofdahl CG,Postma DS,et al.Effect of inhaled formoterol and budesonide on exacerbations of asthma.Formoterol and Corticosteroids Establishing Therapy (FACET) International Study Group.N Engl J Med,1997,337:1405-1411.
9O'Byrne PM,Barnes PJ,Rodriguez-Roisin R,et al.Low dose inhaled budesonide and formoterol in mild persistent asthma:the OPTIMA randomized trial.Am J Respir Crit Care Med,2001,164(8Pt 1):1392-1397.
10Tal A,Simon G,Vermeulen JH,et al.Budesonide/formoterol in a single inhaler versus inhaled corticosteroids alone in the treatment of asthma.Pediatr Pulmonol,2002,34:342-350.
4Mchuys E, Boussery K,Adriaens E, et al. COPD managemem in prima- ry care : an observational, community pharmacy-based study [J]. Ann Pharmacother,2010,44 ( 2 ) :257-266.
5Plaza V,Sanchis J,Roma P,Molina J,Calle M,Quirce S,Viejo JL,Ca- ballero F, Murio C. Physicians' knowledge of inhaler devices and inha- lation techniques remains poor in Spain[J]. J Aerosol Med Pulm Dm8 Deliv ,2012 ,25 ( 1 ) :16-22.
6Jamb AS,Alqudah SG, Khdour M,Shamssain M, Mukattash TL Impact of pharmaceutical care on health outcomes in patients with COPD [J]. Int J Clin Pharm,2012,34( 1 ) :53-62.
7Santos Dde O, Martins MC, Cipfiano SL, Pinto RM, Cukier A, Stelmaeh R. Pharmaceutical care for patients with persistent asthma: assessment of treatment compliance and use of inhaled medications [ J ]. J Brag Pneumo1,2010 ,36 ( 1 ) : 14-22.
8Myrna B ,Dolovich,PEng,et al. Device selection and outcomes of aero- sol therapy: Evienee-based guidelines [ J ]. Chest,2005,127 ( 1 ) : 335- 371.
9Campbell NR,Leiter LA,Larochelle P,et al.Hypertension in diabetes:a call to action.[J].Cana J Cardiol,2009,25(5):299-302.
10Karpov RS,Puzyrev KV,Koshel'skaia OA,et al.Polymorphic markers of GNB3(C825T),AGTR1(A1166C)and ACE(A2350Gand I/D)genes in patients with arterial hypertension combined with diabetes mellitus type 2[J].Терапевтичесκийархив,2010,76(6):30-35.
